Cargando…
Denosumab and muscle performance
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813238/ https://www.ncbi.nlm.nih.gov/pubmed/36378303 http://dx.doi.org/10.1007/s00198-022-06587-5 |
| _version_ | 1784863889695965184 |
|---|---|
| author | Rolvien, Tim Rupp, Tobias Strahl, André Amling, Michael |
| author_facet | Rolvien, Tim Rupp, Tobias Strahl, André Amling, Michael |
| author_sort | Rolvien, Tim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9813238 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer London |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98132382023-01-06 Denosumab and muscle performance Rolvien, Tim Rupp, Tobias Strahl, André Amling, Michael Osteoporos Int Letter to the Editor Springer London 2022-11-15 2023 /pmc/articles/PMC9813238/ /pubmed/36378303 http://dx.doi.org/10.1007/s00198-022-06587-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter to the Editor Rolvien, Tim Rupp, Tobias Strahl, André Amling, Michael Denosumab and muscle performance |
| title | Denosumab and muscle performance |
| title_full | Denosumab and muscle performance |
| title_fullStr | Denosumab and muscle performance |
| title_full_unstemmed | Denosumab and muscle performance |
| title_short | Denosumab and muscle performance |
| title_sort | denosumab and muscle performance |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813238/ https://www.ncbi.nlm.nih.gov/pubmed/36378303 http://dx.doi.org/10.1007/s00198-022-06587-5 |
| work_keys_str_mv | AT rolvientim denosumabandmuscleperformance AT rupptobias denosumabandmuscleperformance AT strahlandre denosumabandmuscleperformance AT amlingmichael denosumabandmuscleperformance |